Global life sciences company Labcorp has announced the first commercially available glial fibrillary acidic protein (GFAP) ...

Preeclampsia is marked by elevated blood ... opposite. Labcorp is in talks with health insurers to see if the test could be ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Labcorp (LH) to $240 from $235 following quarterly results. The firm remains on the sidelines with a Neutral rating on ...

Barclays analyst Stephanie Davis raised the firm’s price target on Labcorp (LH) to $249 from $234 and keeps an Equal Weight rating on the shares post the Q3 report. The firm says Labcorp could ...

Baird raised the firm’s price target on Labcorp (LH) to $289 from $282 and keeps an Outperform rating on the shares. The firm said they posted a strong quarterly update on Diagnostic strength ...

LabCorp (NYSE:LH) coverage was initiated at ... The investment firm set its price target for the stock at $235.

for distribution of its First To Know syphilis test in the U.S. The test provides results in 15 minutes with as little as a single drop of blood. The test will be available to hospitals and clinicians ...

Labcorp to serve as the exclusive NOWDiagnostics ... testing options to include the First to Know® Syphilis Test, the first over-the-counter blood test granted market authorization by the ...

Upgrade your Yahoo Finance plan to get complete details for Labcorp Holdings Inc. Get advanced tools and insights to navigate the markets.